Personalized vaccine shows promise against aggressive brain cancer (glioblastoma) (opens in new tab)

A WashU Medicine-led clinical trial has found that a personalized vaccine to treat glioblastoma appears to increase recurrence-free survival in a subset of patients after surgery.